- 全部删除
- 您的购物车当前为空
Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content. Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling.
Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content. Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 8,990 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 11,230 | 期货 |
产品描述 | Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content. Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling. |
别名 | 芹菜素-7-O-β-D-葡萄糖醛酸甲酯, Apigenin-7-O-β-D-glucuronide methyl ester |
分子量 | 460.39 |
分子式 | C22H20O11 |
CAS No. | 53538-13-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.